Abalone Bio
CA - EmeryvilleBiotechnology
Focus: Abalone Bio is a public biotechnology company founded in 2008 specializing in antibody therapies for oncology. They operate as a lean, focused player in the immuno-oncology space.
Profile data last refreshed 22h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
2
Should You Work at Abalone Bio?
AI assessmentAbalone Bio appears to be a mature, stable but non-growth company; suitable for senior scientists seeking focused antibody expertise without upside potential.
Why Work Here
- Public company status provides equity liquidity and career stability relative to private biotech
- Focused antibody platform in high-value oncology space offers deep technical specialization
Data completeness
3/9 — Basic
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Abalone Bio
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.